Press Release: PEGS : Shattuck Labs to Present at PEGS Summit 2020

DURHAM, N.C. & AUSTIN, Texas--(BUSINESS WIRE)--Shattuck Labs, Inc. ("Shattuck"), an innovative clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC®) platform to develop an entirely new class of biologic medicines for the treatment of cancer and autoimmune disease, today announced its presentation at the PEGS Summit 2020 being held virtually August 31 - September 4, 2020. Presentation Details Presentation Title: CD40 Enhances Type I Interferon Respon